RESUMO
Gliosarcoma, a rare glioblastoma variant, is composed of a glial and a mesenchymal component. Though the mesenchymal portion most commonly resembles a fibrosarcoma, other differentiation patterns have been observed. We present the first genomic characterisation (karyotyping followed by FISH and array comparative genomic hybridisation analysis) of a gliosarcoma with osseous metaplasia. In addition to chromosomal changes often found in gliomas (+7, -10, -13, and -22), the tumour cells also harboured a hitherto unknown t(3;21)(q13â¼21;q21â¼22).
Assuntos
Neoplasias Encefálicas/genética , Neoplasias Encefálicas/patologia , Gliossarcoma/genética , Gliossarcoma/patologia , Ventrículos Laterais/patologia , Idoso , Cromossomos Humanos , Hibridização Genômica Comparativa , Humanos , Hibridização in Situ Fluorescente , Cariotipagem , Masculino , Metaplasia/genéticaRESUMO
In this contribution, a revision of ionizing radiations exposed workers' dosimetric data in four hospital structures is showed, and, consequently, recommended optimization measures are identified.
Assuntos
Recursos Humanos em Hospital , Proteção Radiológica/normas , Humanos , RadiometriaRESUMO
Glioblastoma Multiforme (GBM) is characterized by high cancer cell heterogeneity and the presence of a complex tumor microenvironment. Those factors are a key obstacle for the treatment of this tumor type. To model the disease in mice, the current strategy is to grow GBM cells in serum-free non-adherent condition, which maintains their tumor-initiating potential. However, the so-generated tumors are histologically different from the one of origin. In this work, we performed high-throughput marker expression analysis and investigated the tumorigenicity of GBM cells enriched under different culture conditions. We identified a marker panel that distinguished tumorigenic sphere cultures from non-tumorigenic serum cultures (high CD56, SOX2, SOX9, and low CD105, CD248, αSMA). Contrary to previous work, we found that 'mixed cell cultures' grown in serum conditions are tumorigenic and express cancer stem cell (CSC) markers. As well, 1% serum plus bFGF and TGF-α preserved the tumorigenicity of sphere cultures and induced epithelial-to-mesenchymal transition gene expression. Furthermore, we identified 12 genes that could replace the 840 genes of The Cancer Genome Atlas (TCGA) used for GBM-subtyping. Our data suggest that the tumorigenicity of GBM cultures depend on cell culture strategies that retain CSCs in culture rather than the presence of serum in the cell culture medium.
Assuntos
Carcinogênese/metabolismo , Células-Tronco Mesenquimais/metabolismo , Células-Tronco Neoplásicas/metabolismo , Animais , Técnicas de Cultura de Células , Linhagem Celular Tumoral , Humanos , CamundongosRESUMO
Extraskeletal myxoid chondrosarcoma is a rare malignant soft tissue tumour that can be difficult to diagnose correctly, especially preoperatively. We describe four cases of extraskeletal myxoid chondrosarcoma of the extremities diagnosed by a multimodal approach. The cytological examination of fine-needle aspirates showed small and round, mildly pleomorphic cells lying in sheets and cords, but also dispersed within a myxoid and metachromatic intercellular substance. Histological, electron microscopic and immunocytochemical examination also yielded findings compatible with the diagnosis of extraskeletal myxoid chondrosarcoma. Cytogenetic analysis demonstrated a t(9;22)(q22;q12) in two tumours and a t(9;17)(q22;q11) in the third and fourth. The translocation t(9;22)(q22;q12) has been described repeatedly in extraskeletal myxoid chondrosarcoma but never in other tumours; hence, the detection of this pathognomonic chromosome abnormality in short-term cultured cells from fine-needle aspirates verified the diagnosis in two of the cases. The t(9;17)(q22;q11) found in the last two cases probably represents a new cytogenetic subgroup of extraskeletal myxoid chondrosarcoma as it, too, is unknown in other contexts. The multimodal approach taken in these four cases enabled a definite diagnosis of a rare malignant tumour whose cytological and histological features alone are usually not sufficiently distinct to rule out other differential diagnostic possibilities.
Assuntos
Condrossarcoma/diagnóstico , Condrossarcoma/genética , Cromossomos Humanos Par 17/genética , Cromossomos Humanos Par 9/genética , Neoplasias Musculares/genética , Translocação Genética , Idoso , Condrossarcoma/classificação , Condrossarcoma/ultraestrutura , Diagnóstico Diferencial , Histocitoquímica , Humanos , Imuno-Histoquímica , Cariotipagem , Masculino , Microscopia Eletrônica , Pessoa de Meia-Idade , Neoplasias Musculares/classificação , Neoplasias Musculares/diagnóstico , Neoplasias Musculares/ultraestruturaRESUMO
The MA11 cell line was established from malignant cells isolated from the bone marrow of a breast cancer patient. It metastasizes selectively to the brain in athymic mice. Since the genomic rearrangements of only a few breast cancer cell lines have been characterized completely, we analyzed MA11 cytogenetically. Because the G-banding analysis revealed a very complex karyotype with several markers and chromosomes with additional material of unknown origin, we used multicolor fluorescence in situ hybridization (M-FISH), cross-species color banding (RxFISH), comparative genomic hybridization (CGH), and chromosome-specific probes to better characterize the chromosome abnormalities. The use of these FISH-based screening techniques allowed us to detect previously unsuspected chromosomal changes and determine the identity of chromosomal markers. Multicolor FISH was especially useful to identify the rearranged chromosomes, whereas RxFISH, G-banding, and CGH were instrumental in determining breakpoint positions, although some uncertainties were removed only after hybridization with chromosome-specific probes. The combined analysis revealed a near-triploid karyotype with no less than 20 chromosomes demonstrating structural rearrangements. The resulting imbalances included several of those known to be common in primary breast carcinomas (gain of 1q, 8q, and 20q and loss of 8p, 11q, and 13q), indicating that the MA11 cell line may serve as a good model to study breast carcinogenesis. The full cytogenetic characterization we present may guide future searches for the mechanism of organ-selective metastasis in this model system and, possibly, also in vivo.
Assuntos
Neoplasias da Mama/genética , Aberrações Cromossômicas , Bandeamento Cromossômico , Coloração Cromossômica , Hibridização in Situ Fluorescente , Hibridização de Ácido Nucleico , Feminino , Humanos , Cariotipagem , Células Tumorais CultivadasRESUMO
While the now-classic chromosome banding methods, such as G-banding, remain the techniques of choice for the initial screening for karyotypic abnormalities, sometimes chromosomal rearrangements involve segments too small or too similarly banded to be detected or described adequately by these techniques. The necessity to use a genome-wide, fluorescence in situ hybridization (FISH)-based screening technique as a complement to G-banding is especially obvious in cases where the information obtained by the latter analysis does not provide an adequate guide to the choice of probes for chromosome-specific FISH. Furthermore, the same metaphase cells should ideally be used for both G-banding and FISH analysis to overcome the scarcity of metaphases observed in many cases and to ensure the correct interpretation of chromosomal aberrations in cytogenetically unstable neoplasms with massive cell-to-cell karyotypic variability. We describe a protocol which enables cross-species color banding (RxFISH), a new FISH-based screening technique that simultaneously imparts specific color banding patterns on all chromosomes, of preparations that have been G-banded and mounted for up to several years, as well as a procedure allowing chromosome-specific painting of the same metaphase cells to resolve whatever doubts persist after the preceding G-banding and RxFISH analyses. This approach makes possible a detailed, genome-wide screening for inter- and intrachromosomal abnormalities including archival cases whose karyotypic rearrangements had been incompletely identified by G-banding.
Assuntos
Aneuploidia , Aberrações Cromossômicas , Bandeamento Cromossômico/métodos , Cromossomos Humanos/ultraestrutura , Genoma , Hibridização in Situ Fluorescente/métodos , Adolescente , Idoso , Pré-Escolar , Coloração Cromossômica , Feminino , Humanos , Masculino , Metáfase , Pessoa de Meia-Idade , Síndromes Mielodisplásicas/genética , Síndromes Mielodisplásicas/patologia , Neoplasias/genética , Neoplasias/ultraestrutura , Manejo de EspécimesRESUMO
The most common translocation in non-Hodgkin lymphomas (NHL) is a t(14;18)(q32;q21) recombining the immunoglobulin heavy-chain gene (IGH) on chromosome 14 with the B cell leukemia/lymphoma 2 (BCL2) gene on chromosome 18. Although NHLs carrying a t(14;18) typically begin as low-grade, follicular lymphomas, they have a tendency towards transformation to more aggressive disease, something that is accompanied, presumably caused, by the acquisition of secondary chromosomal changes. One such common change is add(1)(p36), in which material of unknown origin is added to the tip of the short arm of chromosome 1. We used multicolor fluorescence in situ hybridization (M-FISH), a new FISH-based screening technique, to better characterize the rearrangement. Whenever doubt persisted after M-FISH, hybridization with chromosome-specific probes was also performed. In 5 out of 14 informative cases, the extra material on 1p36 could be shown to have come from 17q, more specifically 17q11-21 --> qter, whereas it came from 6p and 11q in two cases each and from 3p, 8p, 8q, 9q, and 12p in one case each. It appears, therefore, that der(1)t(1;17)(p36;q11-21) is a common secondary aberration in NHLs with t(14;18) as the primary abnormality, accounting for about one-third of all add(1)(p36) chromosomes seen in this cytogenetic subset.
Assuntos
Aberrações Cromossômicas , Cromossomos Humanos Par 14 , Cromossomos Humanos Par 18 , Cromossomos Humanos Par 1 , Hibridização in Situ Fluorescente , Linfoma não Hodgkin/genética , Translocação Genética , Bandeamento Cromossômico , HumanosRESUMO
A patient with acute monoblastic leukemia (AML M5a) and the pericentric inversion inv(8)(p11q13) as well as additional chromosome abnormalities in her bone marrow cells is described. This is the fourth known case of inv(8)(p11q13)-positive acute leukemia, and the second such case in which gain of 1q material occurred during clonal evolution. All patients with acute leukemia and inv(8)(p11q13) have been females, most have been young, and there has been a tendency for the disease to run an aggressive course. Both hematologically and cytogenetically, therefore, inv(8)(p11q13)-positive leukemia may be viewed as a variant of AML with t(8;16)(p11;p13). This similarity is also apparent at the molecular genetic level, in-as-much as the MOZ gene in 8p11 is rearranged in both the translocation and the inversion; in t(8;16)-positive leukemia, a MOZ-CBP chimeric gene is generated, whereas inv(8) has been shown to generate a MOZ-TIF2 fusion gene. Southern blot analysis of the present case after MOZ0.8 hybridization of Bam HI digested DNA gave an 11 kb aberrant band in addition to the germline band, corresponding to a breakpoint immediately upstream of the 4 kb long MOZ exon that begins at position 3746. Also previously investigated inv(8)-positive leukemias have shown breaks in this intron indicating that it contains sequence motifs predisposing to illegitimate recombination.
Assuntos
Inversão Cromossômica , Cromossomos Humanos Par 8 , Leucemia Monocítica Aguda/genética , Southern Blotting , Quebra Cromossômica , Análise Citogenética , Feminino , Humanos , Pessoa de Meia-IdadeRESUMO
The aim of this article is to report the preliminary results from a phenomenological study on the lived experience of Alzheimer's caregivers. Eight caregivers involved in caring for two years at list were interviewed. The analysis of interviews by Giorgi's method showed a multidimensional reality synthesizable in eight spheres of themes: Illness, Patient, Caring, Caregiver's Life and Health, Coping, Spouse/Family, Others, Feelings. Illness has a great impact on the caregivers' life and causes the loss of the affected person even before his/her death. Caring is very hard and emotionally involving. Caregivers mainly complain the lack of support from the National Health System. The continuous involvement in caring produces also health problems, depression, and negative effects within the family. Others are considered as bad. The most common feelings are fear for possible accidents to the patients and remorses. Some caregivers have good coping style putting their faith in God, valuing the closeness of the family and living daily. The utility of the eight spheres of themes are discussed in order to guide the practice toward the caregivers.
Assuntos
Doença de Alzheimer , Cuidadores , Adaptação Psicológica , Cuidadores/psicologia , Emoções , Família , Humanos , Entrevistas como Assunto , Fatores de TempoAssuntos
Neoplasias do Endométrio/genética , Sarcoma do Estroma Endometrial/genética , Aberrações Cromossômicas , Neoplasias do Endométrio/patologia , Feminino , Rearranjo Gênico , Genes Supressores de Tumor , Instabilidade Genômica , Humanos , Cariotipagem , Perda de Heterozigosidade , Repetições de Microssatélites/genética , Sarcoma do Estroma Endometrial/patologiaAssuntos
Cromossomos Humanos Par 16 , Cromossomos Humanos Par 1 , Sequenciamento de Nucleotídeos em Larga Escala , Leucemia Eritroblástica Aguda/genética , Fatores de Transcrição NFI/genética , Proteínas Repressoras/genética , Translocação Genética , Proteínas Supressoras de Tumor/genética , HumanosAssuntos
Cromossomos Humanos Par 16/genética , Cromossomos Humanos Par 1/genética , Rearranjo Gênico , Leucemia Eritroblástica Aguda/genética , Proteínas Repressoras/genética , Translocação Genética/genética , Proteínas Supressoras de Tumor/genética , Adolescente , Humanos , Cariotipagem , Leucemia Eritroblástica Aguda/diagnóstico , MasculinoRESUMO
Supernumerary ring chromosomes and/or giant marker chromosomes are often seen in soft-tissue tumors of low-grade or borderline malignancy, such as well-differentiated liposarcomas or atypical lipomas. Classic cytogenetic banding techniques have proved insufficient to identify the genomic composition and structure of such rings and markers, but fluorescent in situ hybridization (FISH) studies have shown that they consist mainly of amplified material from chromosome 12, more specifically from bands 12q13-->q15. We have used the new FISH-based screening techniques comparative genomic hybridization (CGH) and multicolor-FISH (M-FISH) in combination with G-banding and analysis by chromosome- and locus-specific fluorescent in situ probes to examine in detail the karyotypic characteristics of 22 lipomatous tumors, most of them classified histologically as well-differentiated liposarcomas, selected because they had been shown to harbor rings and/or marker chromosomes. M-FISH, in contrast to G- banding, was found to be informative with regard to the chromosomal origin of the rings and other markers present, whereas CGH and hybridizations with locus-specific probes helped identify which subchromosomal regions were involved. We found that chromosome bands 12q15-->q21 were always gained, with 12q15-->q21 being amplified (i.e., a green-to-red ratio >2 by CGH) in 14 of 22 tumors. In three tumors, two distinct but close amplicons in 12q could be identified, corresponding to bands 12q13-->q15 and 12q21. The genomic segment 1q21-->q23 was gained in 12 cases, reaching the level of amplification in seven. Bands 6q24 and 7p15, whose pathogenetic involvement in liposarcomas has not been reported previously, were gained in three cases each. In addition, the rings and giant markers often contained interspersed sequences from several other chromosomes that did not give an equally clear impression of being nonrandomly involved.
Assuntos
Aberrações Cromossômicas , Lipoma/genética , Lipossarcoma/genética , Cromossomos em Anel , Biomarcadores Tumorais/genética , Diferenciação Celular , Bandeamento Cromossômico , Cromossomos Artificiais de Levedura/genética , Humanos , Hibridização in Situ Fluorescente , Cariotipagem , Lipoma/patologia , Lipossarcoma/patologiaRESUMO
Chromosome banding analysis of solid tumors often yields incomplete karyotypes because of the complex rearrangements encountered. The addition of fluorescence in situ hybridization (FISH) methods has helped improve the accuracy of solid tumor cytogenetics, but the absence of screening qualities from standard FISH approaches has proved a severe limitation. We describe the cytogenetic analysis of ten solid tumors using G-banding followed by cross-species color banding (RxFISH), a FISH-based screening technique giving a chromosome-specific banding pattern based on the genomic homologies between humans and gibbons. The addition of RxFISH analysis in all cases led to the identification of previously unidentified intra- as well as interchromosomal rearrangements, thus giving a much more certain and detailed karyotype. In two gastric stromal sarcomas, a tumor type for which no cytogenetic data were hitherto available, numerical chromosomal aberrations dominated, but one of the tumors also carried an unbalanced 7;17-translocation with the same breakpoint in chromosome 17 as that seen in endometrial stromal sarcomas.
Assuntos
Aberrações Cromossômicas , Cariotipagem/métodos , Neoplasias/genética , Bandeamento Cromossômico/métodos , Coloração Cromossômica , Cromossomos Humanos Par 17 , Cromossomos Humanos Par 7 , Humanos , Hibridização in Situ Fluorescente/métodos , Neoplasias/patologia , Neoplasias/cirurgia , Translocação GenéticaRESUMO
Karyotype analysis has depended on chromosome banding techniques since their introduction in about 1970, and the information thus obtained is indispensable for the clinical management of patients with hematologic malignancies. Sometimes, however, chromosomal rearrangements involve segments too small, too similarly banded, or too complex to be described adequately or even to be detected by G-banding. Cross-species color banding is a new FISH-based screening technique that enables the generation of a specific color banding pattern for each human chromosome based on the genomic homologies between man and various species of apes. We report the first application of cross-species color banding (RxFISH) to characterize the chromosomal rearrangements of 10 leukemia samples the G-band karyotypes of which were incomplete. The combination of G-banding and RxFISH in every case yielded additional information beyond that obtained by either technique used alone, determining the identity of even the most complex, inter- as well as intrachromosomal, rearrangements. Genes Chromosomes Cancer 26:13-19, 1999.
Assuntos
Aberrações Cromossômicas , Hibridização in Situ Fluorescente/métodos , Cariotipagem , Leucemia/genética , Adolescente , Adulto , Idoso , Criança , Bandeamento Cromossômico , Deleção Cromossômica , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cromossomos em Anel , Translocação GenéticaRESUMO
Cytogenetic analyses conducted on several cases of melanoma have contributed to the identification of the chromosomal regions where the sequences responsible for malignant transformation and the evolution of this tumor are probably located. With regard to these problems, it is very important to have the possibility to analyze, through the use of cytogenetics, both the primary melanoma and the metastatic lesions from the same patient. We present a case in which the primary melanoma and five different metastases were studied by using cytogenetics. The primary tumor showed an inversion of chromosome 1 where the p36 region, often proposed in literature as the location of a melanoma susceptibility gene, was involved. Three cutaneous and one lymphonodal metastases presented the same nine clonal chromosomal aberrations. In particular, one is a further rearrangement of the marker present in the primary tumor; another is a deletion of the 9p21pter region in which the p16 gene is located. Our results can provide a contribution to the hypothesis of the location of a candidate gene for melanoma in the 1p36 region and can also underscore the role of the 9p21 region in the progression of melanoma.